Cambiar Investors LLC Has $9.21 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cambiar Investors LLC raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 340,234 shares of the medical instruments supplier’s stock after purchasing an additional 10,862 shares during the quarter. Cambiar Investors LLC’s holdings in DENTSPLY SIRONA were worth $9,207,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. UMB Bank n.a. raised its position in DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares during the last quarter. LRI Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the last quarter. Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA during the second quarter valued at about $32,000. Allworth Financial LP boosted its holdings in DENTSPLY SIRONA by 40.2% during the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after purchasing an additional 625 shares during the last quarter. Finally, Central Pacific Bank Trust Division purchased a new position in DENTSPLY SIRONA during the first quarter worth about $64,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $23.49 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $22.85 and a 52-week high of $37.60. The business’s fifty day moving average is $25.12 and its 200 day moving average is $26.27. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. During the same quarter last year, the business posted $0.51 EPS. The business’s quarterly revenue was down 4.3% compared to the same quarter last year. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have commented on XRAY shares. Needham & Company LLC dropped their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Monday, October 28th. Finally, Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and an average target price of $32.67.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.